Compare
02/22/2025 2025-02-22 23:41Compare
| Neuramis Lidocaine remove | Regenovue Fine Plus remove | Miracle L remove | |||||
|---|---|---|---|---|---|---|---|
| Name | Neuramis Lidocaine remove | Regenovue Fine Plus remove | Miracle L remove | ||||
| Image | ![]() | ![]() | ![]() | ||||
| SKU | FM-02-59731 | FM-02-15542 | FM-10-26799 | ||||
| Rating | |||||||
| Price | $32.00 | $42.00 | $269.00 | ||||
| Stock | |||||||
| Availability | |||||||
| Add to cart | |||||||
| Description | |||||||
| Content | Neuramis Lidocaine – Dermal Fillers Injectable Neuramis Lidocaine is a dermal filler created for significant wrinkle correction and facial volume restoration. It enhances balance with lasting outcomes. Key Benefits
Professional Use OnlyNeuramis Lidocaine must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | Regenovue Fine Plus – Dermal Fillers Injectable Regenovue Fine Plus is a high-quality dermal filler developed for fine wrinkle correction. It offers subtle enhancement, natural results, and patient comfort with added lidocaine. Key Benefits
Professional Use OnlyRegenovue Fine Plus must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | Miracle L – Mesotherapy Injectable Miracle L is a hydrating dermal filler formulated to improve skin elasticity and glow. It revitalizes texture and enhances natural softness. Key Benefits
Professional Use OnlyMiracle L must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | ||||
| Weight | N/A | N/A | N/A | ||||
| Dimensions | N/A | N/A | N/A | ||||
| Additional information |
|
|


